The gut-brain axis in schizophrenia

The phrase "gut-brain axis" appears everywhere in popular health writing, often attached to claims that border on miraculous. The actual science is genuinely interesting and also genuinely early. In schizophrenia research specifically, the gut has emerged as a plausible contributor to symptoms and possibly to disease course — but most of the strong claims you will read online run far ahead of the evidence.

This article tries to lay out what is well-supported, what is preliminary, and what is speculation.

What the gut-brain axis actually is

The gut and brain communicate continuously through several channels:

• The vagus nerve, which carries sensory information from the gut directly to the brainstem and back.
• Immune signalling, with cytokines produced in the gut influencing brain inflammation.
• The endocrine system, including gut hormones that affect appetite, mood, and arousal.
• Microbial metabolites, particularly short-chain fatty acids (butyrate, acetate, propionate) produced by gut bacteria from dietary fibre.
• Neurotransmitter precursors, since most of the body's serotonin, for example, is made in the gut (though it largely does not cross the blood-brain barrier).

The gut microbiome — the population of bacteria, archaea, fungi, and viruses living in the digestive tract — affects all these channels.

What schizophrenia research has found so far

Microbiome composition

Multiple small studies have compared the gut microbiomes of people with schizophrenia to healthy controls. The findings are inconsistent in the specifics but tend to point in a similar direction: people with schizophrenia often show reduced microbial diversity, altered ratios of certain bacterial families (such as Lactobacillus, Bifidobacterium, and members of the Ruminococcaceae), and changes in genes involved in producing short-chain fatty acids and amino acid metabolism.

What remains unclear is whether these differences cause anything, are caused by something else (diet, smoking, medication, sedentary lifestyle), or simply mark a population that differs from controls in many ways.

Antipsychotic effects on the microbiome

Several antipsychotics — particularly olanzapine, clozapine, and risperidone — have been shown in animal and human studies to alter gut microbial composition. This has been proposed as one mechanism behind antipsychotic-induced weight gain. Some research, including work using germ-free mice, suggests that olanzapine causes less weight gain when the gut microbiome is depleted.

Intestinal permeability ("leaky gut")

Some studies have found elevated markers of increased intestinal permeability in people with schizophrenia, including soluble CD14 and zonulin. The hypothesis is that a less effective gut barrier allows microbial products (such as lipopolysaccharide, or LPS) to reach the bloodstream, triggering low-grade systemic inflammation that affects the brain. This idea is biologically plausible but the clinical evidence is preliminary.

Maternal microbiome and prenatal risk

Maternal infection during pregnancy is a well-documented modest risk factor for schizophrenia in offspring. Animal models of maternal immune activation produce schizophrenia-like behaviours in the offspring, partly through effects on the gut and immune system. Whether the maternal microbiome plays a role in the human risk is being actively studied.

Probiotics and gut-targeted treatments

Several small, mostly underpowered trials have tested probiotics or specific microbial strains as adjuncts in schizophrenia. Most have looked at gastrointestinal side effects of antipsychotics rather than core psychotic symptoms. A handful have suggested possible improvements in inflammation markers or constipation, but none has shown convincing improvement in psychotic symptoms themselves.

It is too early to recommend specific probiotic strains for schizophrenia. The cleanest evidence-based interventions involving gut-targeted health remain the basics:

• Diet rich in vegetables, fibre, and whole foods (the Mediterranean pattern is the best-studied)
• Regular physical activity
• Adequate sleep
• Avoiding smoking and excessive alcohol
• Active management of antipsychotic-related constipation, which is common and worsens quality of life

The honest summary

Three things appear reasonably well-supported:

1. People with schizophrenia have, on average, gut microbiomes that differ from healthy controls.
2. Antipsychotic medications themselves alter the gut microbiome and may contribute to weight gain through gut-mediated mechanisms.
3. The immune-gut connection is real and may amplify or interact with the immune contribution to schizophrenia discussed in our article on neuroinflammation.

Three things are still genuinely uncertain:

1. Whether changes in the microbiome cause schizophrenia symptoms or merely reflect them
2. Whether targeted probiotic, prebiotic, or dietary interventions improve psychotic symptoms
3. Whether the gut-brain axis matters more in some subgroups than others

What patients can do today

If you are looking for gut-related strategies that have at least some supportive evidence in schizophrenia or general health, the most reasonable steps are:

• Aim for a high-fibre, vegetable-rich diet — the kind that consistently improves microbial diversity in healthy populations
• Stay hydrated and move daily, both of which support gut motility
• Address constipation actively, especially on clozapine
• Discuss probiotic supplementation honestly with your prescriber rather than trying to self-treat psychotic symptoms
• Be wary of any product or programme claiming to "cure" schizophrenia through gut health — these claims uniformly run ahead of the evidence

This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.